Jefferies Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74M Buy
+4,605
New +$1.61M 0.01% 616
2026
Q1
– Sell
-1,445
Closed -$438K – 1757
2025
Q4
$438K Buy
+1,445
New +$451K ﹤0.01% 1372
2025
Q3
– Sell
-3,300
Closed -$796K – 1462
2025
Q2
$796K Buy
+3,300
New +$780K 0.01% 792
2025
Q1
– Sell
-1,807
Closed -$594K – 1636
2024
Q4
$594K Sell
1,807
-5,258
-74% -$1.78M ﹤0.01% 1063
2024
Q3
$2.36M Buy
+7,065
New +$2.24M 0.02% 543
2024
Q2
– Sell
-695
Closed -$240K – 1428
2024
Q1
$240K Sell
695
-1,305
-65% -$429K ﹤0.01% 1284
2023
Q4
$646K Buy
2,000
+1,265
+172% +$396K ﹤0.01% 1116
2023
Q3
$263K Sell
735
-200
-21% -$77.2K ﹤0.01% 1266
2023
Q2
$354K Sell
935
-9,065
-91% -$3.69M ﹤0.01% 1277
2023
Q1
$4.79M Sell
10,000
-6,527
-39% -$3.06M 0.04% 375
2022
Q4
$6.95M Buy
+16,527
New +$6.67M 0.05% 307

Other funds holding BIO

Jefferies Financial Group's BIO Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 4,605 shares worth $1.74M. The stake represents 0.01% of the portfolio and ranks #616 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in BIO as recently as Q4 2025.

Jefferies Financial Group first reported a position in BIO in Q4 2022 and has held it in 11 quarters since. The position peaked at $6.95M in Q4 2022. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Jefferies Financial Group held 4,605 shares of Bio-Rad Laboratories Class A worth $1.74M as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Jefferies Financial Group position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #616 holding.
  • Jefferies Financial Group first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and has held it in 11 quarters since.
  • Jefferies Financial Group's Bio-Rad Laboratories Class A position peaked at $6.95M in Q4 2022.
  • 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.